Carotenoid exposure of Caco-2 intestinal epithelial cells did not affect selected inflammatory markers but altered their proteomic response

British Journal of Nutrition

Volumn 108, Issue 6, 2012, Pages 963-973

  Kaulmann, Anouk ^a   Serchi, Tommaso ^a   Renaut, Jenny ^a   Hoffmann, Lucien ^a   Bohn, Torsten ^a  

^a LUXEMBOURG INSTITUTE OF SCIENCE AND TECHNOLOGY   (Luxembourg)

Author keywords

Caco 2 cells; Carotenoids; Inflammation; Intestinal epithelium; Proteomics

Indexed keywords

BETA CAROTENE; CARRIER PROTEINS AND BINDING PROTEINS; CYCLOOXYGENASE 2; GLUTATHIONE TRANSFERASE A1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 8; LYCOPENE; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; PROFILIN I; PROSTAGLANDIN; PROSTAGLANDIN E2 ALPHA; PROTEOME; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; INFLAMMATION; INTESTINE EPITHELIUM CELL; INTRACELLULAR SIGNALING; MICELLE; PROTEIN EXPRESSION; PROTEOMICS;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BETA CAROTENE; BIOLOGICAL MARKERS; CACO-2 CELLS; CAROTENOIDS; DOWN-REGULATION; ENTEROCYTES; GLUTATHIONE TRANSFERASE; HUMANS; INFLAMMATION MEDIATORS; MICELLES; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; OSMOLAR CONCENTRATION; PEPTIDE MAPPING; PROFILINS; PROTEINS; PROTEOMICS; UP-REGULATION;

EID: 84866111093     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114511006349     Document Type: Article

References (50)

1. Bohn T (2008) Bioavailability of non-provitamin A caroten-oids. Curr Nutr Food Sci 4, 240-258.
2. Giovannucci E (2002) A review of epidemiologic studies of tomatoes, lycopene, and prostate cancer. Exp Biol Med (Maywood) 227, 852-859.
3. Nishino H, Tokuda H, Murakoshi M, et al. (2000) Cancer prevention by natural carotenoids. Biofactors 13, 89-94.
4. Britton G (1995) Structure and properties of carotenoids in relation to function. FASEB J 9, 1551-1558.
5. Riccioni G, D'Orazio N, Speranza L, et al. (2010) Carotenoids and asymptomatic carotid atherosclerosis. J Biol Regul Homeost Agents 24, 447-452.
6. Coyne T, Ibiebele TI, Baade PD, et al. (2005) Diabetes mel-litus and serum carotenoids: findings of a population-based study in Queensland, Australia. Am J Clin Nutr 82, 685-693.
7. Hozawa A, Jacobs DR Jr, Steffes MW, et al. (2006) Associations of serum carotenoid concentrations with the development of diabetes and with insulin concentration: interaction with smoking: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Am J Epidemiol 163, 929-937.
8. Waris G & Ahsan H (2006) Reactive oxygen species: role in the development of cancer and various chronic conditions. J Carcinog 5, 14.
9. Mayne ST (1996) Beta-carotene, carotenoids, and disease prevention in humans. FASEB J 10, 690-701.
10. Wendland BE, Aghdassi E, Tam C, et al. (2001) Lipid peroxidation and plasma antioxidant micronutrients in Crohn disease. Am J Clin Nutr 74, 259-264.
11. Droge W (2002) Free radicals in the physiological control of cell function. Physiol Rev 82, 47-95.
12. Karrasch T & Jobin C (2008) NF-kappaB and the intestine: friend or foe? Inflamm Bowel Dis 14, 114-124.
13. Jantchou P, Monnet E & Carbonnel F (2006) Environmental risk factors in Crohn's disease and ulcerative colitis (excluding tobacco and appendicectomy). Gastroenterol Clin Biol 30, 859-867.
14. Bai SK, Lee SJ, Na HJ, et al. (2005) Beta-carotene inhibits inflammatory gene expression in lipopolysaccharide-stimulated macrophages by suppressing redox-based NF-kappaB activation. Exp Mol Med 37, 323-334.
15. Head KA & Jurenka JS (2003) Inflammatory bowel disease. Part 1: ulcerative colitis-pathophysiology and conventional and alternative treatment options. Altern Med Rev 8, 247-283.
16. Head K & Jurenka JS (2004) Inflammatory bowel disease. Part II: Crohn's disease-pathophysiology and conventional and alternative treatment options. Altern Med Rev 9, 360-401.
17. Jowett SL, Seal CJ, Pearce MS, et al. (2004) Influence of dietary factors on the clinical course of ulcerative colitis: a prospective cohort study. Gut 53, 1479-1484.
18. Rumi G Jr, Szabo I, Vincze A, et al. (2000) Decrease of serum carotenoids in Crohn's disease. J Physiol Paris 94, 159-161.
19. Hengstermann S, Valentini L, Schaper L, et al. (2008) Altered status of antioxidant vitamins and fatty acids in patients with inactive inflammatory bowel disease. Clin Nutr 27, 571-578.
20. Reimund JM, Arondel Y, Escalin G, et al. (2005) Immune activation and nutritional status in adult Crohn's disease patients. Dig Liver Dis 37, 424-431.
21. Maor I, Rainis T, Lanir A, et al. (2008) Oxidative stress, inflammation and neutrophil superoxide release in patients with Crohn's disease: distinction between active and non-active disease. Dig Dis Sci 53, 2208-2214.
22. D'Odorico A, Bortolan S, Cardin R, et al. (2001) Reduced plasma antioxidant concentrations and increased oxidative DNA damage in inflammatory bowel disease. Scand J Gastroenterol 36, 1289-1294.
23. Guslandi M (1998) Nitric oxide and inflammatory bowel diseases. Eur J Clin Invest 28, 904-907.
24. Stein RB, Lichtenstein GR & Rombeau JL (1999) Nutrition in inflammatory bowel disease. Curr Opin Clin Nutr Metab Care 2, 367-371.
25. Chantret I, Rodolosse A, Barbat A, et al. (1994) Differential expression of sucrase-isomaltase in clones isolated from early and late passages of the cell line Caco-2: evidence for glucose-dependent negative regulation. J Cell Sci 107, (Pt 1), 213-225.
26. Biehler E, Hoffmann L, Krause E, et al. (2011) Divalent minerals decrease micellarization and uptake of caroteroids and digestion products into Caco-2 cells. J Nutr 141, 1769-1776.
27. Lasserre JP, Fack F, Revets D, et al. (2009) Effects of the endocrine disruptors atrazine and PCB 153 on the protein expression of MCF-7 human cells. J Proteome Res 8, 5485-5496.
28. Kruger NJ (1994) The Bradford method for protein quanti-tation. Methods Mol Biol 32, 9-15.
29. Souci SW, Fachmann W & Kraut H (1994) Food Composition and Nutrition Tables, 6th ed. Garching: Medpharm.
30. Van De Walle J, Hendrickx A, Romier B, et al. (2010) Inflammatory parameters in Caco-2 cells: effect of stimuli nature, concentration, combination and cell differentiation. Toxicol In vitro 24, 1441-1449.
31. Kunsch C & Rosen CA (1993) NF-kappa B subunit-specific regulation of the interleukin-8 promoter. Mol Cell Biol 13, 6137-6146.
32. Gookin JL, Chiang S, Allen J, et al. (2006) NF-kappaB-mediated expression of iNOS promotes epithelial defense against infection by Cryptosporidium parvum in neonatal piglets. Am J Physiol Gastrointest Liver Physiol 290, G164-G174.
33. Simmons DL, Botting RM & Hla T (2004) Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. Pharmacol Rev 56, 387-437.
34. Romier B, Van De Walle J, During A, et al. (2008) Modulation of signalling nuclear factor-kappaB activation pathway by polyphenols in human intestinal Caco-2 cells. Br J Nutr 100, 542-551.
35. Waugh DJ & Wilson C (2008) The interleukin-8 pathway in cancer. Clin Cancer Res 14, 6735-6741.
36. Wang S, Liu Z, Wang L, et al. (2009) NF-kappaB signaling pathway, inflammation and colorectal cancer. Cell Mol Immunol 6, 327-334.
37. Subbaramaiah K, Yoshimatsu K, Scherl E, et al. (2004) Micro-somal prostaglandin E synthase-1 is overexpressed in inflammatory bowel disease. Evidence for involvement of the transcription factor Egr-1. J Biol Chem 279, 12647-12658.
38. Romier-Crouzet B, Van de Walle J, During A, et al. (2011) Inhibition of inflammatory mediators by polyphenolic plant extracts in human intestinal Caco-2 cells. Food Chem Toxicol 47, 1221-1230.
39. Rachmilewitz D, Stamler JS, Bachwich D, et al. (1995) Enhanced colonic nitric oxide generation and nitric oxide synthase activity in ulcerative colitis and Crohn's disease. Gut 36, 718-723.
40. Chung EY, Roh E, Kwak JA, et al. (2010) alpha-Viniferin suppresses the signal transducer and activation of transcription-1 (STAT-1)-inducible inflammatory genes in interferon-gamma-stimulated macrophages. J Pharmacol Sci 112, 405-414.
41. Johnson GL & Lapadat R (2002) Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298, 1911-1912.
42. De SD, Maiuri MC, Simeon V, et al. (2007) Lycopene, querce-tin and tyrosol prevent macrophage activation induced by gliadin and IFN-gamma. Eur J Pharmacol 566, 192-199.
43. Bouayed J & Bohn T (2010) Exogenous antioxidants-double-edged swords in cellular redox state: health beneficial effects at physiologic doses versus deleterious effects at high doses. Oxid Med Cell Longev 3, 228-237.
44. Unlu NZ, Bohn T, Francis DM, et al. (2007) Lycopene from heat-induced cis-isomer-rich tomato sauce is more bioavail-able than from all-trans-rich tomato sauce in human subjects. Br J Nutr 98, 140-146.
45. Machesky LM & Poland TD (1993) Profilin as a potential mediator of membrane-cytoskeleton communication. Trends Cell Biol 3, 381-385.
46. Caulin C, Ware CF, Magin TM, et al. (2000) Keratin-dependent, epithelial resistance to tumor necrosis factor-induced apoptosis. J Cell Biol 149, 17-22.
47. Lee HW, Hitchcock TM, Park SH, et al. (2010) Involvement of thioredoxin domain-containing 5 in resistance to nitrosa-tive stress. Free Radic Biol Med 49, 872-880.
48. Rahman I & MacNee W (2000) Oxidative stress and regulation of glutathione in lung inflammation. Eur Respir J 16, 534-554.
49. Garrett DA, Failla ML & Sarama RJ (1999) Development of an in vitro digestion method to assess carotenoid bioavailability from meals. J Agric Food Chem 47, 4301-4309.
50. Ferruzzi MG, Lumpkin JL, Schwartz SJ, et al. (2006) Digestive stability, micellarization, and uptake of beta-carotene iso-mers by Caco-2 human intestinal cells. J Agric Food Chem 54, 2780-2785.